Professor
Université de Paris
Paris
Pr Alexandre Alanio is an M.D., Ph.D., expert in medical mycology and medical parasitology. He is currently Professor in Université de Paris (Saint Louis Hospital, Paris, France), Permanent Researcher in the molecular mycology unit and Collaborator of the French National Reference Center for Mycoses and Antifungals.
He received his M.D. from Paris V university medical and its Ph.D. from Paris VII University. He owns more than 100 international publications and 5 international patents. He is currently teaching at the Université de Paris for medical studentsand Master students, and at the Medical Mycology Course of the Institut Pasteur. He is leading a group with 1 engineer, 1 Master student, 2 PhD student and 1 post-doctoral research associate.
He is interested in dormancy and metabolism in Fungi, in particular in Cryptococcus neoformans and in pathophysiology of invasive fungal infections. He aims at bridging medical mycology with basic research on the pathophysiology of invasive fungal infections and translating new biological tools (bench) into diagnostic test for fungal and parasitic infections (bedside).
On the bedside, he is actively working on the development of new molecular diagnostic tools for pneumocystosis, histoplasmosis, mucormycosis, aspergillosis, and other mold infections. He is also interested in the molecular epidemiology of antifungal resistance in clinically relevant fungi, in particular Aspergillus fumigatus or Candida glabrata. He recently published the ECIL-5 recommendation for the diagnosis of pneumocystosis in hematology patients and is part of the ISHAM Aspergillus resistance working group. He is member of ECCMID, ISHAM and ASM and is currently editor of Microbiology spectrum (ASM) and mBio (ASM), and associate editor for Pathogens, Journal of Clinical Microbiology and Frontiers in Cellular and Infection Microbiology.
Astellas (Individual(s) Involved: Self): Research Grant or Support; GIlead (Individual(s) Involved: Self): Other Financial or Material Support, Personnal fees for education; Pfizer (Individual(s) Involved: Self): Board Member
113 - Optimizing Molecular Testing in Algorithms for the Diagnosis of Challenging Fungal Pathogens
Friday, October 1, 2021
4:15 PM - 5:30 PM EDT
Molecular Diagnosis of Mucormycosis
Friday, October 1, 2021
4:15 PM - 5:30 PM EDT